Chinese haematology specialist Lu Daopei Medical Group has closed over 500 million yuan ($72 million) in a Series B round of equity financing led by Singaporean state-owned firm Temasek Holdings, with participation from Bahrain-based alternative investment firm Investcorp, according to a statement on Tuesday.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
